Nicotinamide mononucleotide (NMN) intake increases plasma NMN and insulin levels in healthy subjects
Nicotinamide adenine dinucleotide (NAD+) is a coenzyme of the NAD+-dependent protein deacetylase sirtuin-1 (SIRT1). An increase in NAD+ concentration induces SIRT1 activation that results in various health benefits. Since nicotinamide mononucleotide (NMN) is a precursor of NAD+, NMN ingestion is exp...
Saved in:
| Published in | Clinical nutrition ESPEN Vol. 56; pp. 83 - 86 |
|---|---|
| Main Authors | , , , |
| Format | Journal Article |
| Language | English |
| Published |
England
Elsevier Ltd
01.08.2023
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Nicotinamide adenine dinucleotide (NAD+) is a coenzyme of the NAD+-dependent protein deacetylase sirtuin-1 (SIRT1). An increase in NAD+ concentration induces SIRT1 activation that results in various health benefits. Since nicotinamide mononucleotide (NMN) is a precursor of NAD+, NMN ingestion is expected to have multiple health benefits such as alleviation of aging, lifestyle-related and neurodegenerative diseases, through the activation of SIRT1. In this study, we aimed to determine the effects of daily NMN ingestion on plasma levels of NMN and NAD+.
Healthy volunteers received 250 mg of NMN once a day in the morning (n = 11) for 12 weeks, and the plasma concentrations of NMN and NAD+ were measured monthly. Physiological and laboratory tests were performed within 2 h after lunch (at 2 pm) before and during NMN administration.
Oral administration of NMN increased the plasma concentrations of NMN and NAD+, and the postprandial serum insulin levels. The elevation levels of NMN and insulin varied widely among individuals. No adverse symptoms were observed in the participants.
Oral administration of NMN elevates plasma levels of NMN and NAD+, and postprandial serum insulin levels. |
|---|---|
| AbstractList | Nicotinamide adenine dinucleotide (NAD
) is a coenzyme of the NAD
-dependent protein deacetylase sirtuin-1 (SIRT1). An increase in NAD
concentration induces SIRT1 activation that results in various health benefits. Since nicotinamide mononucleotide (NMN) is a precursor of NAD
, NMN ingestion is expected to have multiple health benefits such as alleviation of aging, lifestyle-related and neurodegenerative diseases, through the activation of SIRT1. In this study, we aimed to determine the effects of daily NMN ingestion on plasma levels of NMN and NAD
.
Healthy volunteers received 250 mg of NMN once a day in the morning (n = 11) for 12 weeks, and the plasma concentrations of NMN and NAD
were measured monthly. Physiological and laboratory tests were performed within 2 h after lunch (at 2 pm) before and during NMN administration.
Oral administration of NMN increased the plasma concentrations of NMN and NAD
, and the postprandial serum insulin levels. The elevation levels of NMN and insulin varied widely among individuals. No adverse symptoms were observed in the participants.
Oral administration of NMN elevates plasma levels of NMN and NAD
, and postprandial serum insulin levels. Nicotinamide adenine dinucleotide (NAD+) is a coenzyme of the NAD+-dependent protein deacetylase sirtuin-1 (SIRT1). An increase in NAD+ concentration induces SIRT1 activation that results in various health benefits. Since nicotinamide mononucleotide (NMN) is a precursor of NAD+, NMN ingestion is expected to have multiple health benefits such as alleviation of aging, lifestyle-related and neurodegenerative diseases, through the activation of SIRT1. In this study, we aimed to determine the effects of daily NMN ingestion on plasma levels of NMN and NAD+. Healthy volunteers received 250 mg of NMN once a day in the morning (n = 11) for 12 weeks, and the plasma concentrations of NMN and NAD+ were measured monthly. Physiological and laboratory tests were performed within 2 h after lunch (at 2 pm) before and during NMN administration. Oral administration of NMN increased the plasma concentrations of NMN and NAD+, and the postprandial serum insulin levels. The elevation levels of NMN and insulin varied widely among individuals. No adverse symptoms were observed in the participants. Oral administration of NMN elevates plasma levels of NMN and NAD+, and postprandial serum insulin levels. INTRODUCTIONNicotinamide adenine dinucleotide (NAD+) is a coenzyme of the NAD+-dependent protein deacetylase sirtuin-1 (SIRT1). An increase in NAD+ concentration induces SIRT1 activation that results in various health benefits. Since nicotinamide mononucleotide (NMN) is a precursor of NAD+, NMN ingestion is expected to have multiple health benefits such as alleviation of aging, lifestyle-related and neurodegenerative diseases, through the activation of SIRT1. In this study, we aimed to determine the effects of daily NMN ingestion on plasma levels of NMN and NAD+. METHODSHealthy volunteers received 250 mg of NMN once a day in the morning (n = 11) for 12 weeks, and the plasma concentrations of NMN and NAD+ were measured monthly. Physiological and laboratory tests were performed within 2 h after lunch (at 2 pm) before and during NMN administration. RESULTSOral administration of NMN increased the plasma concentrations of NMN and NAD+, and the postprandial serum insulin levels. The elevation levels of NMN and insulin varied widely among individuals. No adverse symptoms were observed in the participants. CONCLUSIONSOral administration of NMN elevates plasma levels of NMN and NAD+, and postprandial serum insulin levels. |
| Author | Bamba, Takeshi Yamane, Takuya Imai, Momoko Uchiyama, Susumu |
| Author_xml | – sequence: 1 givenname: Takuya orcidid: 0000-0002-0408-6425 surname: Yamane fullname: Yamane, Takuya email: takuya.yamane@bio.eng.osaka-u.ac.jp organization: Institute of Metabolomics, BYU-Analytica Inc., Suita, Osaka, 565-0871, Japan – sequence: 2 givenname: Momoko surname: Imai fullname: Imai, Momoko organization: Institute of Metabolomics, BYU-Analytica Inc., Suita, Osaka, 565-0871, Japan – sequence: 3 givenname: Takeshi surname: Bamba fullname: Bamba, Takeshi organization: Institute of Metabolomics, BYU-Analytica Inc., Suita, Osaka, 565-0871, Japan – sequence: 4 givenname: Susumu orcidid: 0000-0002-5181-179X surname: Uchiyama fullname: Uchiyama, Susumu organization: Institute of Metabolomics, BYU-Analytica Inc., Suita, Osaka, 565-0871, Japan |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37344088$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kM1OwzAQhC1UREvpGyCUIxwa7MSJkwsSqviTSrnA2XLsreriOCWbVOrb46oFceK0u94Zz-o7JwPfeCDkktGYUZbfrmPtPOAmTmiSxpTHNGUnZJRwmk15JsTgTz8kE8Q1pcFXlpzRMzJMRco5LYoRMQurm856VVsDUd2EnF47CE9hvF68Lm4i6zv1CaHoFhQCRhunsFZRWEbKm7DA3lkfOdiCwzBGK1CuW-0i7Ks16A4vyOlSOYTJsY7Jx-PD--x5On97epndz6c6HNNNTQbMMKVMJZgqS8NoJapsqVlqeEWBpZUJOgPFMskLnRem5KXIRZaVIFgBPB2T68O_m7b56gE7WVvU4Jzy0PQokyIpRJZzngcpP0h12yC2sJSb1taq3UlG5R6xXMsDYrlHLCmXAXGwXR0T-qoG82v6ARoEdwdBQAFbC61EbcFrMLYNKKRp7P8J3zkkkP4 |
| CitedBy_id | crossref_primary_10_1507_endocrj_EJ23_0431 crossref_primary_10_1172_JCI174824 |
| Cites_doi | 10.1016/j.clnu.2022.02.015 10.1139/o59-099 10.3389/fnut.2022.868640 10.3390/ijms23084306 10.1124/mol.105.015750 10.1016/j.cmet.2007.09.003 10.1111/ceo.13818 10.1038/s41598-019-46120-z 10.1038/ncomms12948 10.1126/science.abe9985 10.1016/S0140-6736(04)15786-3 10.1152/physrev.00022.2011 10.1038/s42255-018-0009-4 10.1038/s41467-018-03421-7 10.1016/j.cmet.2011.08.014 10.1124/mol.106.030833 10.1093/hmg/ddac077 10.1016/j.cmet.2017.11.002 10.1042/BST20180420 10.1056/NEJMoa1506197 10.1038/s41598-021-87759-x 10.1111/jocd.12119 10.1210/endocr/bqac023 10.1111/1523-1747.ep12499963 10.1507/endocrj.EJ19-0313 10.3389/fcell.2020.00246 10.3177/jnsv.68.151 10.1007/s001250051536 10.1186/s12970-021-00442-4 10.1111/exd.13819 10.1038/jid.2011.459 10.3390/nu14040755 |
| ContentType | Journal Article |
| Copyright | 2023 The Authors Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved. |
| Copyright_xml | – notice: 2023 The Authors – notice: Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved. |
| DBID | 6I. AAFTH NPM AAYXX CITATION 7X8 |
| DOI | 10.1016/j.clnesp.2023.04.031 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access PubMed CrossRef MEDLINE - Academic |
| DatabaseTitle | PubMed CrossRef MEDLINE - Academic |
| DatabaseTitleList | PubMed MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Diet & Clinical Nutrition |
| EISSN | 2405-4577 |
| EndPage | 86 |
| ExternalDocumentID | 10_1016_j_clnesp_2023_04_031 37344088 S2405457723001249 |
| Genre | Journal Article |
| GroupedDBID | --M .1- .FO .~1 1P~ 1~. 457 4G. 53G 6I. 7-5 8P~ AACTN AAEDT AAEDW AAFTH AAIAV AAKOC AALRI AAOAW AAXUO ABLVK ABMAC ABMZM ABXDB ABYKQ ACDAQ ACGFS ACRLP ADBBV ADEZE AEBSH AEVXI AFCTW AFKWA AFRHN AFTJW AFXIZ AGHFR AGUBO AIEXJ AIKHN AISVY AITUG AJBFU AJOXV AJUYK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX AXJTR BKOJK BLXMC BNPGV EBS EFJIC EFLBG EJD FDB FIRID FYGXN GBLVA KOM OAUVE OC. ON0 Q38 ROL SDF SNG SPCBC SSH SSZ T5K Z5R ~G- 0R~ AAHBH AAXKI ADVLN AFJKZ NPM AAYXX CITATION 7X8 |
| ID | FETCH-LOGICAL-c408t-d5e1d1aadb71a99d10b7b5fc13d4b0e13bd408de8f268c68d949767559e718e43 |
| IEDL.DBID | AIKHN |
| ISSN | 2405-4577 |
| IngestDate | Thu Oct 24 23:12:43 EDT 2024 Thu Sep 26 19:01:02 EDT 2024 Wed Oct 16 00:39:56 EDT 2024 Fri Feb 23 02:36:59 EST 2024 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | NAD Insulin NMN |
| Language | English |
| License | This is an open access article under the CC BY license. Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c408t-d5e1d1aadb71a99d10b7b5fc13d4b0e13bd408de8f268c68d949767559e718e43 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0002-5181-179X 0000-0002-0408-6425 |
| OpenAccessLink | https://www.sciencedirect.com/science/article/pii/S2405457723001249 |
| PMID | 37344088 |
| PQID | 2828756446 |
| PQPubID | 23479 |
| PageCount | 4 |
| ParticipantIDs | proquest_miscellaneous_2828756446 crossref_primary_10_1016_j_clnesp_2023_04_031 pubmed_primary_37344088 elsevier_sciencedirect_doi_10_1016_j_clnesp_2023_04_031 |
| PublicationCentury | 2000 |
| PublicationDate | August 2023 2023-Aug 2023-08-00 20230801 |
| PublicationDateYYYYMMDD | 2023-08-01 |
| PublicationDate_xml | – month: 08 year: 2023 text: August 2023 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | Clinical nutrition ESPEN |
| PublicationTitleAlternate | Clin Nutr ESPEN |
| PublicationYear | 2023 |
| Publisher | Elsevier Ltd |
| Publisher_xml | – name: Elsevier Ltd |
| References | Kim, Seol, Sato, Fukamizu, Sakurai, Okura (bib11) 2022; 14 Trammell, Schmidt, Weidermann, Redpath, Jaksch, Dellinger (bib25) 2016; 7 Yoshino, Mills, Yoon, Imai (bib6) 2011; 14 Nadeeshani, Li, Ying, Zhang, Lu (bib30) 2022; 37 Liao, Zhao, Wang, Zhang, Hao, Hu (bib10) 2021; 18 Rolfe (bib20) 2014; 13 (bib18) 2004; 363 Morrow, Awad, Oates, Roberts (bib14) 1992; 98 Conze, Brenner, Kruger (bib27) 2019; 9 Benyό, Gille, Bennet, Clausen, Offermanns (bib16) 2006; 70 Yang, Deng, Yu, Luo, Chen, Zheng (bib32) 2022; 13 Parsons, Kocinaj, Ruiz Pulido, Prendergast, Parsons, Facey (bib33) 2022; 31 Yoshino, Baur, Imai (bib3) 2018; 27 Irie, Inagaki, Fujita, Nakaya, Mitsuishi, Yamaguchi (bib8) 2020; 67 D'Andrea, Hey, Ramirez, Kesselheim (bib12) 2019; 2 Hong, Mo, Zhang, Huang, Wei (bib2) 2020; 8 Tunaru, Lӓttig, Kero, Krause, Offermanns (bib15) 2005; 68 Bligh, Dyer (bib31) 1959; 37 Berger, Shenkin, Schweinlin, Amerein, Augsburger, Biesalski (bib13) 2022; 41 Chen, Martin, Choy, Fernández-Peñas, Dalziell, McKenzie (bib21) 2015; 373 Hui, Tang, Williams, McGuinness, Hadoux, Casson (bib23) 2020; 48 Nogueiras, Habegger, Chaudhary, Finan, Banks, Dietrich (bib4) 2012; 92 Okabe, Yaku, Uchida, Fukamizu, Sato, Sakurai (bib28) 2022; 9 Knip, Douek, Moore, Gillmor, McLean, Bingley (bib17) 2000; 43 Pietris (bib24) 2022; 68 Revollo, Körner, Mills, Satoh, Wang, Garten (bib34) 2007; 6 Martens, Denman, Mazzo, Armstrong, Reisdorph, McQueen (bib26) 2018; 9 Snaidr, Damian, Halliday (bib22) 2019; 28 Nagahisa, Yamaguchi, Kosugi, Homma, Miyashita, Irie (bib7) 2022; 163 Takasawa (bib35) 2022; 23 Makarov, Trammell, Migaud (bib1) 2019; 47 Yoshino, Yoshino, Kayser, Patti, Franczyk, Mills (bib9) 2021; 372 Grozio, Mills, Yoshino, Bruzzone, Sociali, Tokizane (bib29) 2019; 1 Surjana, Halliday, Martin, Moloney, Damian (bib19) 2012; 132 Majeed, Halabi, Madani, Engelke, Bhagwat, Abdesselem (bib5) 2021; 11 Okabe (10.1016/j.clnesp.2023.04.031_bib28) 2022; 9 Nogueiras (10.1016/j.clnesp.2023.04.031_bib4) 2012; 92 Grozio (10.1016/j.clnesp.2023.04.031_bib29) 2019; 1 Tunaru (10.1016/j.clnesp.2023.04.031_bib15) 2005; 68 Nagahisa (10.1016/j.clnesp.2023.04.031_bib7) 2022; 163 Rolfe (10.1016/j.clnesp.2023.04.031_bib20) 2014; 13 Irie (10.1016/j.clnesp.2023.04.031_bib8) 2020; 67 Berger (10.1016/j.clnesp.2023.04.031_bib13) 2022; 41 Benyό (10.1016/j.clnesp.2023.04.031_bib16) 2006; 70 Kim (10.1016/j.clnesp.2023.04.031_bib11) 2022; 14 Revollo (10.1016/j.clnesp.2023.04.031_bib34) 2007; 6 Surjana (10.1016/j.clnesp.2023.04.031_bib19) 2012; 132 Trammell (10.1016/j.clnesp.2023.04.031_bib25) 2016; 7 Morrow (10.1016/j.clnesp.2023.04.031_bib14) 1992; 98 Conze (10.1016/j.clnesp.2023.04.031_bib27) 2019; 9 Makarov (10.1016/j.clnesp.2023.04.031_bib1) 2019; 47 Liao (10.1016/j.clnesp.2023.04.031_bib10) 2021; 18 Pietris (10.1016/j.clnesp.2023.04.031_bib24) 2022; 68 Yoshino (10.1016/j.clnesp.2023.04.031_bib3) 2018; 27 Bligh (10.1016/j.clnesp.2023.04.031_bib31) 1959; 37 Snaidr (10.1016/j.clnesp.2023.04.031_bib22) 2019; 28 Takasawa (10.1016/j.clnesp.2023.04.031_bib35) 2022; 23 Hui (10.1016/j.clnesp.2023.04.031_bib23) 2020; 48 Knip (10.1016/j.clnesp.2023.04.031_bib17) 2000; 43 Parsons (10.1016/j.clnesp.2023.04.031_bib33) 2022; 31 Yang (10.1016/j.clnesp.2023.04.031_bib32) 2022; 13 (10.1016/j.clnesp.2023.04.031_bib18) 2004; 363 Yoshino (10.1016/j.clnesp.2023.04.031_bib9) 2021; 372 Majeed (10.1016/j.clnesp.2023.04.031_bib5) 2021; 11 Nadeeshani (10.1016/j.clnesp.2023.04.031_bib30) 2022; 37 D'Andrea (10.1016/j.clnesp.2023.04.031_bib12) 2019; 2 Hong (10.1016/j.clnesp.2023.04.031_bib2) 2020; 8 Yoshino (10.1016/j.clnesp.2023.04.031_bib6) 2011; 14 Martens (10.1016/j.clnesp.2023.04.031_bib26) 2018; 9 Chen (10.1016/j.clnesp.2023.04.031_bib21) 2015; 373 |
| References_xml | – volume: 363 start-page: 925 year: 2004 end-page: 931 ident: bib18 article-title: European Nicotinamide Diabetes Intervention Trial (ENDIT) group. European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes publication-title: Lancet – volume: 37 start-page: 911 year: 1959 end-page: 917 ident: bib31 article-title: A rapid method of total lipid extraction and purification publication-title: Can J Biochem Physiol contributor: fullname: Dyer – volume: 9 start-page: 1286 year: 2018 ident: bib26 article-title: Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults publication-title: Nat Commun contributor: fullname: McQueen – volume: 8 start-page: 246 year: 2020 ident: bib2 article-title: Nicotinamide mononucleotide: a promising molecule for therapy of diverse diseases by targeting NAD publication-title: Front Cell Dev Biol contributor: fullname: Wei – volume: 2 year: 2019 ident: bib12 article-title: Assessment of the role of niacin in managing cardiovascular disease outcomes. A systematic review and meta-analysis publication-title: JAMA Netw Open contributor: fullname: Kesselheim – volume: 68 start-page: 1271 year: 2005 end-page: 1280 ident: bib15 article-title: Characterization of determinants of ligand binding to the nicotinic acid receptor GPR109A (HM74A/PUMA-G) publication-title: Mol Pharmacol contributor: fullname: Offermanns – volume: 48 start-page: 903 year: 2020 end-page: 914 ident: bib23 article-title: Improvement in inner retinal function in glaucoma with nicotinamide (vitamin B3) supplementation: a crossover randomized clinical trial publication-title: Clin Experiment Ophtalmol contributor: fullname: Casson – volume: 6 start-page: 363 year: 2007 end-page: 375 ident: bib34 article-title: Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme publication-title: Cell Metabol contributor: fullname: Garten – volume: 92 start-page: 1479 year: 2012 end-page: 1514 ident: bib4 article-title: Sirtuin 1 and sirtuin 3: physiological modulators of metabolism publication-title: Physiol Rev contributor: fullname: Dietrich – volume: 14 start-page: 528 year: 2011 end-page: 536 ident: bib6 article-title: Nicotinamide mononucleotide, a key NAD publication-title: Cell Metabol contributor: fullname: Imai – volume: 372 start-page: 1224 year: 2021 end-page: 1229 ident: bib9 article-title: Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women publication-title: Science contributor: fullname: Mills – volume: 163 year: 2022 ident: bib7 article-title: Intestinal epithelial NAD publication-title: Endocrinology contributor: fullname: Irie – volume: 68 start-page: 151 year: 2022 end-page: 154 ident: bib24 article-title: The role of NAD+ and nicotinamide (vitamin B3) in glaucoma: a literature review publication-title: J Nutr Sci Vitaminol contributor: fullname: Pietris – volume: 28 start-page: 15 year: 2019 end-page: 22 ident: bib22 article-title: Nicotinamide for photoprotection and skin cancer chemoprevention: a review of efficacy and safety publication-title: Exp Dermatol contributor: fullname: Halliday – volume: 37 start-page: 267 year: 2022 end-page: 278 ident: bib30 article-title: Nicotinamide mononucleotide (NMN) as anti-aging health product–promises and safety concerns publication-title: J Advanced Res contributor: fullname: Lu – volume: 13 year: 2022 ident: bib32 article-title: Association of human whole blood NAD+ contents with aging publication-title: Front Endocrinol contributor: fullname: Zheng – volume: 373 start-page: 1618 year: 2015 end-page: 1626 ident: bib21 article-title: A phase 3 randomized trial of nicotinamide for skinˆcancer chemoprevention publication-title: N Engl J Med contributor: fullname: McKenzie – volume: 9 year: 2022 ident: bib28 article-title: Oral administration of nicotinamide mononucleotide is safe and efficiently increases blood nicotinamide adenine dinucleotide levels in healthy subjects publication-title: Front Nutr contributor: fullname: Sakurai – volume: 70 start-page: 1844 year: 2006 end-page: 1849 ident: bib16 article-title: Nicotinic acid -induced flushing is mediated by activation of epidermal Langerhans cells publication-title: Mol Pharmacol contributor: fullname: Offermanns – volume: 11 start-page: 8177 year: 2021 ident: bib5 article-title: SIRT1 promotes lipid metabolism and mitochondrial biogenesis in adipocytes and coordinates adipogenesis by targeting key enzymatic pathways publication-title: Sci Rep contributor: fullname: Abdesselem – volume: 41 start-page: 1357 year: 2022 end-page: 1424 ident: bib13 article-title: ESPEN micronutrient guideline publication-title: Clin Nutr contributor: fullname: Biesalski – volume: 27 start-page: 513 year: 2018 end-page: 528 ident: bib3 article-title: NAD publication-title: Cell Metabol contributor: fullname: Imai – volume: 14 start-page: 755 year: 2022 ident: bib11 article-title: Effect of 12-week intake of nicotinamide mononucleotide on sleep quality, fatigue, and physical performance in older Japanese adults: a randomized, double-blind placebo-controlled study publication-title: Nutrients contributor: fullname: Okura – volume: 9 start-page: 9772 year: 2019 ident: bib27 article-title: Safety and metabolism of long-term administration of NIAGEN (nicotinamide riboside chloride) in a randomized, double-blind, placebo-contorolled clinical trial of healthy overweight adults publication-title: Sci Rep contributor: fullname: Kruger – volume: 1 start-page: 47 year: 2019 end-page: 57 ident: bib29 article-title: Slc12a8 is a nicotinamide mononucleotide transporter publication-title: Nat Metab contributor: fullname: Tokizane – volume: 132 start-page: 1497 year: 2012 end-page: 1500 ident: bib19 article-title: Oral administration reduces actinic keratoses in phase II double-blinded randomized controlled trials publication-title: J Invest Dermatol contributor: fullname: Damian – volume: 31 start-page: 2918 year: 2022 end-page: 2933 ident: bib33 article-title: Alpha-synucleinopathy reduces NMNAT3 protein levels and neurite formation that can be rescued by targeting the NAD+ pathway publication-title: Hum Mol Genet contributor: fullname: Facey – volume: 98 start-page: 812 year: 1992 end-page: 815 ident: bib14 article-title: Identification of skin as a major site of prostaglandin D2 release following oral administration of niacin in humans publication-title: J Invest Dermatol contributor: fullname: Roberts – volume: 67 start-page: 153 year: 2020 end-page: 160 ident: bib8 article-title: Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men publication-title: Endocr J contributor: fullname: Yamaguchi – volume: 13 start-page: 324 year: 2014 end-page: 328 ident: bib20 article-title: A review of nicotinamide: treatment of skin diseases and potential side effects publication-title: J Cosmet Dermatol contributor: fullname: Rolfe – volume: 18 start-page: 54 year: 2021 ident: bib10 article-title: Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: a randomized, double-blind study publication-title: J Int Soc Sports Nutr contributor: fullname: Hu – volume: 43 start-page: 1337 year: 2000 end-page: 1345 ident: bib17 article-title: Safety of high-dose nicotinamide: a review publication-title: Diabetologia contributor: fullname: Bingley – volume: 47 start-page: 131 year: 2019 end-page: 147 ident: bib1 article-title: The chemistry of the vitamin B3 metabolome publication-title: Biochem Soc Trans contributor: fullname: Migaud – volume: 7 year: 2016 ident: bib25 article-title: Nicotinamide riboside is uniquely and orally bioavailable in mice and humans publication-title: Nat Commun contributor: fullname: Dellinger – volume: 23 start-page: 4306 year: 2022 ident: bib35 article-title: CD38-cyclic ADP-ribose signal system in physiology, biochemistry, and pathophysiology publication-title: Int J Mol Sci contributor: fullname: Takasawa – volume: 41 start-page: 1357 year: 2022 ident: 10.1016/j.clnesp.2023.04.031_bib13 article-title: ESPEN micronutrient guideline publication-title: Clin Nutr doi: 10.1016/j.clnu.2022.02.015 contributor: fullname: Berger – volume: 37 start-page: 911 issue: 8 year: 1959 ident: 10.1016/j.clnesp.2023.04.031_bib31 article-title: A rapid method of total lipid extraction and purification publication-title: Can J Biochem Physiol doi: 10.1139/o59-099 contributor: fullname: Bligh – volume: 9 year: 2022 ident: 10.1016/j.clnesp.2023.04.031_bib28 article-title: Oral administration of nicotinamide mononucleotide is safe and efficiently increases blood nicotinamide adenine dinucleotide levels in healthy subjects publication-title: Front Nutr doi: 10.3389/fnut.2022.868640 contributor: fullname: Okabe – volume: 23 start-page: 4306 issue: 8 year: 2022 ident: 10.1016/j.clnesp.2023.04.031_bib35 article-title: CD38-cyclic ADP-ribose signal system in physiology, biochemistry, and pathophysiology publication-title: Int J Mol Sci doi: 10.3390/ijms23084306 contributor: fullname: Takasawa – volume: 68 start-page: 1271 year: 2005 ident: 10.1016/j.clnesp.2023.04.031_bib15 article-title: Characterization of determinants of ligand binding to the nicotinic acid receptor GPR109A (HM74A/PUMA-G) publication-title: Mol Pharmacol doi: 10.1124/mol.105.015750 contributor: fullname: Tunaru – volume: 6 start-page: 363 issue: 5 year: 2007 ident: 10.1016/j.clnesp.2023.04.031_bib34 article-title: Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme publication-title: Cell Metabol doi: 10.1016/j.cmet.2007.09.003 contributor: fullname: Revollo – volume: 48 start-page: 903 year: 2020 ident: 10.1016/j.clnesp.2023.04.031_bib23 article-title: Improvement in inner retinal function in glaucoma with nicotinamide (vitamin B3) supplementation: a crossover randomized clinical trial publication-title: Clin Experiment Ophtalmol doi: 10.1111/ceo.13818 contributor: fullname: Hui – volume: 9 start-page: 9772 year: 2019 ident: 10.1016/j.clnesp.2023.04.031_bib27 article-title: Safety and metabolism of long-term administration of NIAGEN (nicotinamide riboside chloride) in a randomized, double-blind, placebo-contorolled clinical trial of healthy overweight adults publication-title: Sci Rep doi: 10.1038/s41598-019-46120-z contributor: fullname: Conze – volume: 7 year: 2016 ident: 10.1016/j.clnesp.2023.04.031_bib25 article-title: Nicotinamide riboside is uniquely and orally bioavailable in mice and humans publication-title: Nat Commun doi: 10.1038/ncomms12948 contributor: fullname: Trammell – volume: 372 start-page: 1224 issue: 6547 year: 2021 ident: 10.1016/j.clnesp.2023.04.031_bib9 article-title: Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women publication-title: Science doi: 10.1126/science.abe9985 contributor: fullname: Yoshino – volume: 363 start-page: 925 year: 2004 ident: 10.1016/j.clnesp.2023.04.031_bib18 article-title: European Nicotinamide Diabetes Intervention Trial (ENDIT) group. European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes publication-title: Lancet doi: 10.1016/S0140-6736(04)15786-3 – volume: 92 start-page: 1479 year: 2012 ident: 10.1016/j.clnesp.2023.04.031_bib4 article-title: Sirtuin 1 and sirtuin 3: physiological modulators of metabolism publication-title: Physiol Rev doi: 10.1152/physrev.00022.2011 contributor: fullname: Nogueiras – volume: 1 start-page: 47 year: 2019 ident: 10.1016/j.clnesp.2023.04.031_bib29 article-title: Slc12a8 is a nicotinamide mononucleotide transporter publication-title: Nat Metab doi: 10.1038/s42255-018-0009-4 contributor: fullname: Grozio – volume: 9 start-page: 1286 year: 2018 ident: 10.1016/j.clnesp.2023.04.031_bib26 article-title: Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults publication-title: Nat Commun doi: 10.1038/s41467-018-03421-7 contributor: fullname: Martens – volume: 14 start-page: 528 issue: 4 year: 2011 ident: 10.1016/j.clnesp.2023.04.031_bib6 article-title: Nicotinamide mononucleotide, a key NAD+ intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice publication-title: Cell Metabol doi: 10.1016/j.cmet.2011.08.014 contributor: fullname: Yoshino – volume: 70 start-page: 1844 year: 2006 ident: 10.1016/j.clnesp.2023.04.031_bib16 article-title: Nicotinic acid -induced flushing is mediated by activation of epidermal Langerhans cells publication-title: Mol Pharmacol doi: 10.1124/mol.106.030833 contributor: fullname: Benyό – volume: 31 start-page: 2918 issue: 17 year: 2022 ident: 10.1016/j.clnesp.2023.04.031_bib33 article-title: Alpha-synucleinopathy reduces NMNAT3 protein levels and neurite formation that can be rescued by targeting the NAD+ pathway publication-title: Hum Mol Genet doi: 10.1093/hmg/ddac077 contributor: fullname: Parsons – volume: 27 start-page: 513 year: 2018 ident: 10.1016/j.clnesp.2023.04.031_bib3 article-title: NAD+ intermediates: the biology and therapeutic potential of NMN and NR publication-title: Cell Metabol doi: 10.1016/j.cmet.2017.11.002 contributor: fullname: Yoshino – volume: 47 start-page: 131 year: 2019 ident: 10.1016/j.clnesp.2023.04.031_bib1 article-title: The chemistry of the vitamin B3 metabolome publication-title: Biochem Soc Trans doi: 10.1042/BST20180420 contributor: fullname: Makarov – volume: 373 start-page: 1618 year: 2015 ident: 10.1016/j.clnesp.2023.04.031_bib21 article-title: A phase 3 randomized trial of nicotinamide for skinˆcancer chemoprevention publication-title: N Engl J Med doi: 10.1056/NEJMoa1506197 contributor: fullname: Chen – volume: 11 start-page: 8177 year: 2021 ident: 10.1016/j.clnesp.2023.04.031_bib5 article-title: SIRT1 promotes lipid metabolism and mitochondrial biogenesis in adipocytes and coordinates adipogenesis by targeting key enzymatic pathways publication-title: Sci Rep doi: 10.1038/s41598-021-87759-x contributor: fullname: Majeed – volume: 37 start-page: 267 year: 2022 ident: 10.1016/j.clnesp.2023.04.031_bib30 article-title: Nicotinamide mononucleotide (NMN) as anti-aging health product–promises and safety concerns publication-title: J Advanced Res contributor: fullname: Nadeeshani – volume: 13 start-page: 324 year: 2014 ident: 10.1016/j.clnesp.2023.04.031_bib20 article-title: A review of nicotinamide: treatment of skin diseases and potential side effects publication-title: J Cosmet Dermatol doi: 10.1111/jocd.12119 contributor: fullname: Rolfe – volume: 163 issue: 4 year: 2022 ident: 10.1016/j.clnesp.2023.04.031_bib7 article-title: Intestinal epithelial NAD+ biosynthesis regulates GLP-1 production and postprandial glucose metabolism in mice publication-title: Endocrinology doi: 10.1210/endocr/bqac023 contributor: fullname: Nagahisa – volume: 98 start-page: 812 year: 1992 ident: 10.1016/j.clnesp.2023.04.031_bib14 article-title: Identification of skin as a major site of prostaglandin D2 release following oral administration of niacin in humans publication-title: J Invest Dermatol doi: 10.1111/1523-1747.ep12499963 contributor: fullname: Morrow – volume: 67 start-page: 153 issue: 2 year: 2020 ident: 10.1016/j.clnesp.2023.04.031_bib8 article-title: Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men publication-title: Endocr J doi: 10.1507/endocrj.EJ19-0313 contributor: fullname: Irie – volume: 8 start-page: 246 year: 2020 ident: 10.1016/j.clnesp.2023.04.031_bib2 article-title: Nicotinamide mononucleotide: a promising molecule for therapy of diverse diseases by targeting NAD+ metabolism publication-title: Front Cell Dev Biol doi: 10.3389/fcell.2020.00246 contributor: fullname: Hong – volume: 2 year: 2019 ident: 10.1016/j.clnesp.2023.04.031_bib12 article-title: Assessment of the role of niacin in managing cardiovascular disease outcomes. A systematic review and meta-analysis publication-title: JAMA Netw Open contributor: fullname: D'Andrea – volume: 68 start-page: 151 year: 2022 ident: 10.1016/j.clnesp.2023.04.031_bib24 article-title: The role of NAD+ and nicotinamide (vitamin B3) in glaucoma: a literature review publication-title: J Nutr Sci Vitaminol doi: 10.3177/jnsv.68.151 contributor: fullname: Pietris – volume: 43 start-page: 1337 year: 2000 ident: 10.1016/j.clnesp.2023.04.031_bib17 article-title: Safety of high-dose nicotinamide: a review publication-title: Diabetologia doi: 10.1007/s001250051536 contributor: fullname: Knip – volume: 18 start-page: 54 issue: 1 year: 2021 ident: 10.1016/j.clnesp.2023.04.031_bib10 article-title: Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: a randomized, double-blind study publication-title: J Int Soc Sports Nutr doi: 10.1186/s12970-021-00442-4 contributor: fullname: Liao – volume: 28 start-page: 15 year: 2019 ident: 10.1016/j.clnesp.2023.04.031_bib22 article-title: Nicotinamide for photoprotection and skin cancer chemoprevention: a review of efficacy and safety publication-title: Exp Dermatol doi: 10.1111/exd.13819 contributor: fullname: Snaidr – volume: 13 year: 2022 ident: 10.1016/j.clnesp.2023.04.031_bib32 article-title: Association of human whole blood NAD+ contents with aging publication-title: Front Endocrinol contributor: fullname: Yang – volume: 132 start-page: 1497 year: 2012 ident: 10.1016/j.clnesp.2023.04.031_bib19 article-title: Oral administration reduces actinic keratoses in phase II double-blinded randomized controlled trials publication-title: J Invest Dermatol doi: 10.1038/jid.2011.459 contributor: fullname: Surjana – volume: 14 start-page: 755 issue: 4 year: 2022 ident: 10.1016/j.clnesp.2023.04.031_bib11 article-title: Effect of 12-week intake of nicotinamide mononucleotide on sleep quality, fatigue, and physical performance in older Japanese adults: a randomized, double-blind placebo-controlled study publication-title: Nutrients doi: 10.3390/nu14040755 contributor: fullname: Kim |
| SSID | ssj0001699410 |
| Score | 2.3134737 |
| Snippet | Nicotinamide adenine dinucleotide (NAD+) is a coenzyme of the NAD+-dependent protein deacetylase sirtuin-1 (SIRT1). An increase in NAD+ concentration induces... Nicotinamide adenine dinucleotide (NAD ) is a coenzyme of the NAD -dependent protein deacetylase sirtuin-1 (SIRT1). An increase in NAD concentration induces... INTRODUCTIONNicotinamide adenine dinucleotide (NAD+) is a coenzyme of the NAD+-dependent protein deacetylase sirtuin-1 (SIRT1). An increase in NAD+... |
| SourceID | proquest crossref pubmed elsevier |
| SourceType | Aggregation Database Index Database Publisher |
| StartPage | 83 |
| SubjectTerms | Insulin NAD NMN |
| Title | Nicotinamide mononucleotide (NMN) intake increases plasma NMN and insulin levels in healthy subjects |
| URI | https://dx.doi.org/10.1016/j.clnesp.2023.04.031 https://www.ncbi.nlm.nih.gov/pubmed/37344088 https://search.proquest.com/docview/2828756446 |
| Volume | 56 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwEB212wsXxDcLpTISQnAwG68dOz5WhWoBNReo1Jtlx14pZUlXJHvgwm_vTD6oeqiQOEV24sTyOG-e7fEzwJvgtY62ynhMRnFVCM1DjJHryhiLiGhToHnIs1KvztWXi_xiD06mvTAUVjli_4DpPVqPOYuxNRfbul58Q1-E7h_ZoSSfrew-HPSLRDM4OP78dVXeTLVoa1WvS0BFOJWZNtH1kV7VBlGFtCuXspc9leIuJ3UXCe2d0ekDuD-ySHY8VPQh7KXmEcw_1qljb9ko9blh5aS0_xgiWbyr6fT5mBh2vauGhIwxC5PvyrPyPaubzv9IeCEe2aaWbZFY__QMbzLfRDZGrbMNhRm1mGTDHsrfrN0Fms1pn8D56afvJys-HrDAK5UVHY95ElF4H4MR3toosmBCvq6EjCpkScgQ8bmYivVSF5UuolWWxF9ym9ClJSWfwgzrm54DQ1rio5FrfJtEWPDBL72RJCcoUoU0aA58alG3HXQ03BRgdukGCziygMuUQwvMwUzN7m71B4dQ_4-SrycrOfxVaP3DN-lq1zoaXZocCaCew7PBfH_rIo2ks7eLF__93Zdwj1JDcOAhzLpfu_QKCUsXjmD_wx9xNHbLazGz6fE |
| link.rule.ids | 315,783,787,4511,24130,27938,27939,45599,45693 |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwEB2VcoAL4puFAkZCCA5m47Vjx8eqUC3QzYVW6s2yY68Uuk1XJHvgwm9nJh8gDhUSp8hxnFieyZsXZ_wM8Dp4raOtMh6TUVwVQvMQY-S6MsYiItoUaB5yVerlmfp8np_vwdG0FobSKkfsHzC9R-vxzHwczfm2rudfMRZh-Ed2KClmK3sDbirSz0Knfv9T_Jlo0daqXpWAGnBqMS2h6_O8qg1iCilXLmQveirFdSHqOgrah6Lju3Bn5JDscOjmPdhLzX2YfahTx96wUehzw8pJZ_8BRLJ3V9Pe8zExdLyrhmSM8RQW35ar8h2rm85fJDwQi2xTy7ZIqy89w0rmm8jGnHW2oSSjFotsWEH5g7W7QHM57UM4O_54erTk4_YKvFJZ0fGYJxGF9zEY4a2NIgsm5OtKyKhCloQMEa-LqVgvdFHpIlplSfoltwkDWlLyEexjf9MTYEhKfDRyjXeTCAo--IU3ksQERaqQBM2ATyPqtoOKhpvSy765wQKOLOAy5dACMzDTsLu_vMEh0P-j5avJSg5fFPr74Zt0tWsdfVuaHOmfnsHjwXy_-yKNpJ23i6f__dyXcGt5ujpxJ5_KL8_gNtUMaYIHsN9936XnSF268KJ3zV9mcerT |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Nicotinamide+mononucleotide+%28NMN%29+intake+increases+plasma+NMN+and+insulin+levels+in+healthy+subjects&rft.jtitle=Clinical+nutrition+ESPEN&rft.au=Yamane%2C+Takuya&rft.au=Imai%2C+Momoko&rft.au=Bamba%2C+Takeshi&rft.au=Uchiyama%2C+Susumu&rft.date=2023-08-01&rft.eissn=2405-4577&rft.volume=56&rft.spage=83&rft_id=info:doi/10.1016%2Fj.clnesp.2023.04.031&rft_id=info%3Apmid%2F37344088&rft.externalDocID=37344088 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2405-4577&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2405-4577&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2405-4577&client=summon |